Article: Geron to Present at Four Investor Conferences.(Conference news)

MENLO PARK, Calif. -- Geron Corporation (Nasdaq:GERN) today announced that the company will present updates of its product development programs at four investor conferences in the month of September.

Stephen M. Kelsey, M.D., F.R.C.P., F.R.C.Path., executive vice president and chief medical officer for oncology, will review Geron's portfolio of anti-cancer therapies, including its telomerase inhibitor drug (imetelstat - GRN163L) and its telomerase therapeutic vaccine (GRNVAC1) at the following conference:

* Rodman & Renshaw 11th Annual Healthcare Conference in New York, NY, at 9:35 am ET on Thursday, September 10, 2009.

Thomas B. Okarma, Ph.D., ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!